About this page

Our systems have detected unusual traffic from your computer network. This page checks to see if it's really you sending the requests, and not a robot. Why did this happen?

IP address: 18.233.223.189
Time: 2024-03-28T15:11:37Z
URL: http://scholar.google.com/scholar_lookup?title=Phase+I%2FII+trial+evaluating+the+anti-vascular+endothelial+growth+factor+monoclonal+antibody+bevacizumab+in+combination+with+the+HER-1%2Fepidermal+growth+factor+receptor+tyrosine+kinase+inhibitor+erlotinib+for+patients+with+recurrent+non-small-cell+lung+cancer&year=2005&author=Herbst&journal=J+Clin+Oncol&volume=23&issue=11&pages=2544-2555&doi=10.1200%2FJCO.2005.02.477&pmid=15753462